Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOICE: Pain Management and Opioid Safety in Veterans
NCT03026790Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Oct 2017
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine + naloxone in chronic pain, sponsored by University of Minnesota. Started Oct 2017; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03026790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026790.